EUVIMEDEUVIMED entdecken
Crossref

Ofatumumab in the treatment of multiple sclerosis – from clinical outcomes to the economic sustainability of treatment

Simona Halúsková, Martin Vališ, Zbyšek Pavelek

Česká a slovenská neurologie a neurochirurgie · 28.02.2026 · 122 (1)

DOI: 10.48095/cccsnn20269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Česká a slovenská neurologie a neurochirurgie, online erschienen am 28.02.2026. Verfasst von Simona Halúsková und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Halúsková, S., Vališ, M., & Pavelek, Z. (2026). Ofatumumab in the treatment of multiple sclerosis – from clinical outcomes to the economic sustainability of treatment. Česká a slovenská neurologie a neurochirurgie, 122(1). https://doi.org/10.48095/cccsnn20269

Vancouver

Halúsková S, Vališ M, Pavelek Z. Ofatumumab in the treatment of multiple sclerosis – from clinical outcomes to the economic sustainability of treatment. Česká a slovenská neurologie a neurochirurgie. 2026;122(1). doi:10.48095/cccsnn20269

BibTeX
@article{Halskov2026,
  author = {Halúsková, Simona and Vališ, Martin and Pavelek, Zbyšek},
  title = {Ofatumumab in the treatment of multiple sclerosis – from clinical outcomes to the economic sustainability of treatment},
  journal = {Česká a slovenská neurologie a neurochirurgie},
  year = {2026},
  volume = {122},
  number = {1},
  doi = {10.48095/cccsnn20269}
}
Kostenlos starten →